BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Incyte’s Graft-Versus-Host Trial Fails to Meet Primary Endpoint

  Company shares dropped almost 10% at the news.

  January 3, 2020

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Novan’s Molluscum Trial Barely Misses Primary Endpoint

  The company emphasizes that the data was “near statistically significant” in B-SIMPLE2 and was statistically significant in the secondary endpoint and several pre-specified sensitivity analyses.

  January 3, 2020

   · 

  2 min read

   · 

  Mark Terry
• 

  Deals

  Following Antitrust Concerns, Illumina and Pacific Bio Call Off $1.2 Billion Merger

  The two companies cited a lengthy regulatory approval process and “continued uncertainty” of the outcome of the merger as the primary reasons behind the termination of the deal.

  January 3, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  What Does 2020 Have in Store for the Life Sciences?

  BioSpace spoke to leaders from various corners of the industry who provided their insights into what the coming year is likely to hold for their particular sphere.

  January 3, 2020

   · 

  4 min read

   · 

  Alex Keown
• 

  Career Advice

  Behavioral Interviewing Strategies

  Behavioral interviewing is touted as providing a more objective set of facts to make employment decisions than other interviewing methods. Read to learn more.

  January 3, 2020

   · 

  5 min read

   · 

  Katharine Hansen, PhD
• 

  Researchers Identify Epigenetic Inhibiting Drugs to Kill Resistant Malaria Parasites

  Researchers recently identified molecules that can inhibit DNA methylation and kill even the most resistant of the malaria parasites, Plasmodium falciparum.

  January 3, 2020

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  Durect Drug Fails to Shine in Mid-Stage Plaque Psoriasis Trial

  As a result, the company is abandoning the development of the product for this indication and focusing the asset on liver diseases.

  January 3, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Top Life Sciences Startups to Watch in 2020

  BioSpace is proud to present its NextGen Bio “Class of 2020,” a list of up-and-coming life science companies in North America that launched no earlier than mid-2018.

  January 3, 2020

   · 

  13 min read

   · 

  Mark Terry
• 

  Pharm Country

  Janssen Does Not Want Crohn’s Disease Asset Back from Provention Following Trial Failure

  Janssen will assist with transferring the manufacturing rights of PRV-6527 to either Provention for continued development or assist in the transference of rights to a third party.

  January 3, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Clinical Catch-Up: December 30, 2019 – January 2, 2020

  Even with the holiday week, there was still some clinical trial news coming out. Here’s a look.

  January 3, 2020

   · 

  6 min read

   · 

  Mark Terry